Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation

被引:0
|
作者
LI Min ZHANG Li-ping YANG Lu Department of Anesthesiology.Peking University Third Hospital
机构
关键词
liver transplantation; fluid therapy; coagulation; blood;
D O I
暂无
中图分类号
R657.3 [肝及肝管];
学科分类号
1002 ; 100210 ;
摘要
Background There have been many studies investigating the impact of the model for end-stage liver disease(MELD)score on predicting post-transplant outcome.But it is unclear whether MELD is correlated to intraoperative fluid therapyand coagulation status.We investigated the relationship between the severity of liver diseases as measured by MELDscore and intraoperative fluid requirements and the changes of coagulation characteristics.Methods Ninety patients were included in this retrospective study.The patients were stratified into three groupsaccording to the MELD scores:<15(low),15-25(medium)and>25(high).Intraoperatively,volume was restored withallogeneic and/or salvaged red blood cells(RBC),fresh-frozen plasma(FFP),platelet and other types of fluids accordingto hemodynamic data,hematocrit,and clotting data.Intraoperative coagulation data,blood requirements and other fluidsadministered were compared among the 3 groups.Results Before surgery,in addition to the three variables used to calculate MELD scores in other baseline laboratoryvalues,including ratio of activated partial thromboplastin time(R-APTT),D-Dimer,hematocrit,platelet and blood ureanitrogen(BUN)were significantly different among the 3 groups.The blood loss increased with increasing MELD.Thevolume of RBC(allogeneinc,salvaged and total),FFP,platelet and the total volume of transfusion were also significantlydifferent among the three groups(P<0.01).The requirements for prothrombin complex and fibrinogen showed a similarpattern.During operation,the changing trends of each coagulation variable were different.Compared with baseline,during each intraoperative stage,INR and R-APPT increased in the low MELD group.While in the medium MELD andhigh MELD groups,INR did not changed significantly during the operation,and R-APPT significantly increased only afterrepeffusion.Conclusions This study provided some useful information for perioperative management of patients undergoing livertransplantation.Careful preoperative planning and resource preparation are crucial for patients with high MELD scores.Close communication between surgeon,anesthesiologist and the transfusion staff of blood bank before and duringsurgery should be stressed.
引用
收藏
页码:1963 / 1968
页数:6
相关论文
共 50 条
  • [21] ASSOCIATION BETWEEN HELICOBACTER PYLORI AND END-STAGE LIVER DISEASE IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
    Huesing, A.
    Spieker, T.
    Wilms, C.
    Heinzow, H.
    Maschmeier, M.
    Hartmann, W.
    Gruenewald, I.
    Schmidt, H. H. -J.
    Kabar, I.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 39 - 39
  • [22] Significance of sarcopenia in children with end-stage liver disease undergoing liver transplantation
    Kyrana, Eirini
    PEDIATRIC TRANSPLANTATION, 2021, 25 (05)
  • [23] Should Liver Transplantation in Patients with Model for End-Stage Liver Disease Scores ≤ 14 Be Avoided? A Decision Analysis Approach
    Perkins, James D.
    Halldorson, Jeffrey B.
    Bakthavatsalam, Ramasamy
    Fix, Oren K.
    Carithers, Robert L., Jr.
    Reyes, Jorge D.
    LIVER TRANSPLANTATION, 2009, 15 (02) : 242 - 254
  • [24] Orthotopic liver transplantation in treatment of 77patients with end-stage hepatic disease
    Shu-Sen Zheng
    Dong-Sheng Huang
    Wei-Lin Wang
    Ting--Bo Liang
    Min Zhang
    Yan Shen
    Xiao Xu
    Jian Wu
    Sheng Yan
    Hua Guo
    An-Wei Lu From the Department of Hepatobiliary Surgery
    Hepatobiliary&PancreaticDiseasesInternational, 2002, (01) : 8 - 13
  • [25] Model for end-stage liver disease scores do not predict liver transplantation waiting list morbidity
    Cowling, T
    Jennings, LW
    Ueno, T
    Martin, P
    Sanchez, EQ
    Chinnakotla, S
    Randall, H
    Dawson, S
    Goldstein, RM
    Klintmalm, GB
    Levy, MF
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 516 - 516
  • [26] Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores
    Wronka, Karolina Maria
    Grat, Michal
    Stypulkowski, Jan
    Bik, Emil
    Krasnodebski, Maciej
    Masior, Lukasz
    Grat, Karolina
    Patkowski, Waldemar
    Krawczyk, Marek
    ANNALS OF TRANSPLANTATION, 2017, 22 : 251 - 256
  • [27] Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation
    Carrion, Andres F.
    Khaderi, Saira A.
    Sussman, Norman L.
    LIVER TRANSPLANTATION, 2016, 22 (03) : 279 - 280
  • [28] Reply: Clinically Relevant Differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease-Sodium Scores
    Xiol, Xavier
    Castellote, Jose
    Fuentes-Arderiu, Xavier
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1904 - 1904
  • [29] Mind the Model for End-Stage Liver Disease: Model for End-Stage Liver Disease Score as an Indicator of Hemoderivate Transfusion and Survival in Liver Transplantation
    Alonso, I. J.
    Maestro, O. C.
    Gomez, N. F.
    Mateos, R. S.
    Quinto, A. M.
    Molero, F. C.
    Municio, A. M.
    Pulido, J. C.
    Segurola, C. L.
    Romero, C. J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 97 - 99
  • [30] Endoscopic stenting of the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease awaiting orthotopic liver transplantation
    Shrestha, R
    Trouillot, TE
    Everson, GT
    LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (04): : 275 - 281